carbidopa and n-methyl-3,4-methylenedioxyamphetamine

carbidopa has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gudelsky, GA; Nash, JF1
Bernardi, G; Federici, M; Mercuri, NB; Natoli, S; Sebastianelli, L1

Other Studies

2 other study(ies) available for carbidopa and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Journal of neurochemistry, 1996, Volume: 66, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Fluoxetine; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tetrodotoxin

1996
Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
    Biological psychiatry, 2007, Sep-15, Volume: 62, Issue:6

    Topics: Action Potentials; Amphetamine; Animals; Autoreceptors; Carbidopa; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hallucinogens; Membrane Potentials; Mesencephalon; N-Methyl-3,4-methylenedioxyamphetamine; Neural Inhibition; Neurons; Pindolol; Receptors, Dopamine D2; Ventral Tegmental Area

2007